If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTrifast Regulatory News (TRI)

Share Price Information for Trifast (TRI)

Share Price is delayed by 15 minutes
Get Live Data
77.00    0.00 (0.00%)
Bid:
66.40
Ask:
0.00
Spread: 13.20 (19.88%)
Market Cap: £103.98m
TRI Live PriceLast checked at - London Stock Exchange

Intraday Trifast Share Chart

LTIP awards targets and Total Voting Rights

12 Feb 2021 11:41

RNS Number : 9736O
Trifast PLC
12 February 2021
 

Friday, 12 February 2021

Trifast plc

(the "Company")

PERFORMANCE CONDITIONS FOR LTIP AWARDS GRANTED ON 25 NOVEMBER 2020 UNDER TRIFAST PLC's EMPLOYEE SHARE PLAN

Trifast plc (the Company) granted a Nil-Cost Option over shares (the Awards) under the Employee Share Plan on 25 November 2020 to the CEO and CFO as listed in the table below.

 

Name

Role

Number of Shares subject to Award

Mark Belton

CEO

380,701

Clare Foster

CFO

291,666

 

As disclosed in the FY2020 Directors' Remuneration Report, the Committee felt it was unlikely that it would be able to robustly set three-year EPS targets for the Awards as at their grant date, given the significant uncertainty in the wider economic environment. On this basis, the Committee agreed to determine the EPS targets applicable to the Awards within six months from the Date of Grant, in line with the Investment Association's concession.

 

The Committee has now conducted a review of the EPS targets taking account of the internal business plan, the outlook for the sector and general macroeconomic conditions. Following careful consideration, the Committee approved the target range set out below with EPS stated as an absolute figure which needs to be achieved in the financial year ending 31 March 2023.

 

The Committee is cognisant that the threshold level of EPS in FY2023 is broadly flat compared to the Company's FY2020 results. The Committee noted that given the projected outcome for FY2021, threshold performance represents significant growth over the next two financial years and that this growth trajectory will be reflected in the targets for the FY2021 LTIP award. Finally, the Committee was comfortable that threshold performance was in excess of analysts' consensus forecast for FY2023.

 

The relative TSR performance measure is unchanged from that previously disclosed in the FY2020 Directors' Remuneration Report and will be measured over a three-year performance period ending 31 March 2023.

 

Measure

Threshold

(25% vesting)

Maximum

(100% vesting)

Underlying diluted EPS ('EPS') (70% weighting)

10.55p in FY2023

13.28p in FY2023

Total Shareholder Return ('TSR') relative to FTSE Small Cap excluding investment trusts (30% weighting)

Equal to index return

8% p.a. in excess of index return

 

1. Vesting between threshold and maximum performance is based on a sliding scale

2. TSR growth for Trifast and the FTSE Small Cap Index (excluding investment trusts) will be measured using a three-month average prior to the start and the end of the three-year performance period 

 

 

In line with the Directors' Remuneration Policy approved at the 2020 AGM, the Committee will have overriding discretion to change the formulaic vesting outcome of this award (both downwards and upwards) if it is out of line with the underlying performance of the Company.

Total voting rights (TVR)

The Company's total issued share capital is 136,012,462 Ordinary Shares with one voting right per share. The Company does not hold any Ordinary Shares in Treasury. Therefore, the total number of voting rights in the company is 136,012,462. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the Financial Conduct Authority's Disclosure and Transparency Rules.

 

 

Enquiries:

Trifast plc

Lyndsey Case

Company Secretary

Tel: +44(0)1825 769696

www.trifast.com

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
STRFLFVLFTIFLIL
Date   Source Headline
6th Jul 202612:00 pmRNSHolding(s) in Company
6th Jul 202611:53 amRNSDirector/PDMR Shareholding
2nd Jul 20267:00 amRNSFinal Results
26th Jun 20269:33 amRNSHolding(s) in Company
11th Jun 20267:00 amRNSChange of Adviser
3rd Jun 20267:46 amRNSDirector Declaration
5th May 20261:03 pmRNSHolding(s) in Company
29th Apr 20267:00 amRNSTrading Statement
17th Apr 20267:00 amRNSDirector/PDMR Shareholding
31st Mar 20261:44 pmRNSDirector/PDMR Shareholding
30th Mar 20267:00 amRNSHolding(s) in Company
27th Mar 20262:53 pmRNSHolding(s) in Company
27th Mar 20262:43 pmRNSDirector/PDMR Shareholding
17th Feb 20261:15 pmRNSDirector/PDMR Shareholding
16th Feb 20263:02 pmRNSHolding(s) in Company
12th Feb 20267:00 amRNSTrading Statement
19th Jan 20268:34 amRNSDirector Declaration
9th Jan 202611:02 amRNSDirector/PDMR Shareholding
23rd Dec 202512:35 pmRNSHolding(s) in Company
23rd Dec 202512:35 pmRNSHolding(s) in Company
23rd Dec 202512:35 pmRNSHolding(s) in Company
18th Nov 20257:00 amRNSHalf-year Financial Report
23rd Oct 20255:10 pmRNSDirector/PDMR Shareholding
21st Oct 20257:00 amRNSTrading Statement
15th Oct 20253:06 pmRNSDirector/PDMR Shareholding
7th Oct 20259:01 amRNSDirector/PDMR Shareholding
12th Sep 20257:00 amRNSBoard Fellow Appointment
11th Sep 20251:31 pmRNSResult of AGM
11th Sep 20257:00 amRNSTrading Statement
5th Sep 20253:00 pmRNSDirector/PDMR Shareholding
18th Aug 20251:21 pmRNSDirector/PDMR Shareholding
28th Jul 20253:19 pmRNSDirector/PDMR Shareholding
22nd Jul 20258:08 amRNSNotice of AGM
14th Jul 20251:44 pmRNSDirector/PDMR Shareholding - Replacement
14th Jul 20251:17 pmRNSDirector/PDMR Shareholding
10th Jul 20257:00 amRNSFinal Results
27th Jun 20252:50 pmRNSNotice of Results
4th Jun 20257:00 amRNSTotal Voting Rights
19th May 20255:02 pmRNSHolding(s) in Company
30th Apr 20257:00 amRNSTrading Update & Notice of FY25 Annual Results
16th Apr 20253:02 pmRNSShare purchases under Dividend Re-Investment Plan
11th Apr 20257:00 amRNSDirector/PDMRs share purchases
2nd Apr 20251:25 pmRNSBlock listing Interim Review
27th Mar 20252:15 pmRNSDirector/PDMR Shareholding
24th Mar 202512:12 pmRNSDirector/PDMR Shareholding - Purchase of Shares
13th Feb 20257:00 amRNSTrading update
5th Feb 202511:19 amRNSDirector/PDMR Shareholding
4th Feb 20253:54 pmRNSDirector/PDMR Shareholding
28th Jan 20252:07 pmRNSDirector/PDMR Shareholding
27th Jan 20255:15 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.